Swinging lever mechanism of myosin directly shown by time-resolved cryo-EM
Myosins produce force and movement in cells through interactions with F-actin<sup>1</sup>. Generation of movement is thought to arise through actin-catalysed conversion of myosin from an ATP-generated primed (pre-powerstroke) state to a post-powerstroke state, accompanied by myosin lever swing<sup>2,3</sup>. However, the initial, primed actomyosin state has never been observed, and the mechanism by which actin catalyses myosin ATPase activity is unclear. Here, to address these issues, we performed time-resolved cryogenic electron microscopy (cryo-EM)<sup>4</sup> of a myosin-5 mutant having slow hydrolysis product release<sup>5,6</sup>. Primed actomyosin was predominantly captured 10 ms after mixing primed myosin with F-actin, whereas post-powerstroke actomyosin predominated at 120 ms, with no abundant intermediate states detected. For detailed interpretation, cryo-EM maps were fitted with pseudo-atomic models. Small but critical changes accompany the primed motor binding to actin through its lower 50-kDa subdomain, with the actin-binding cleft open and phosphate release prohibited. Amino-terminal actin interactions with myosin promote rotation of the upper 50-kDa subdomain, closing the actin-binding cleft, and enabling phosphate release. The formation of interactions between the upper 50-kDa subdomain and actin creates the strong-binding interface needed for effective force production. The myosin-5 lever swings through 93°, predominantly along the actin axis, with little twisting. The magnitude of lever swing matches the typical step length of myosin-5 along actin<sup>7</sup>. These time-resolved structures demonstrate the swinging lever mechanism, elucidate structural transitions of the power stroke, and resolve decades of conjecture on how myosins generate movement.
Authors
- Michele Stofella (ORCID: https://orcid.org/0000-0002-4533-1319)
- Donald A. Winkelmann (ORCID: https://orcid.org/0000-0003-1932-2379)
- Jennifer L. Atherton
- Frank Sobott (ORCID: https://orcid.org/0000-0001-9029-1865)
- Howard D. White (ORCID: https://orcid.org/0000-0003-1066-2051)
- David P. Klebl (ORCID: https://orcid.org/0000-0002-3581-8334)
- Charlotte A. Scarff (ORCID: https://orcid.org/0000-0001-6168-0060)
- Éva Forgács
- Sean N. McMillan (ORCID: https://orcid.org/0000-0002-6833-5523)
- Vitold E. Galkin (ORCID: https://orcid.org/0000-0003-1138-7565)
- Sarah Anne Harris (ORCID: https://orcid.org/0000-0002-2812-1651)
- Cristina M. Risi (ORCID: https://orcid.org/0000-0002-3145-2072)
- Peter J. Knight (ORCID: https://orcid.org/0000-0002-8850-9500)
- Betty Virok
- Stephen P. Muench (ORCID: https://orcid.org/0000-0001-6869-4414)
Institutions
- Rutgers, The State University of New Jersey (US)
- University of Leeds (GB)
- Johnson University (US)
- Max Planck Institute of Biochemistry (DE)
- Institute of Structural and Molecular Biology (GB)
- Old Dominion University (US)
- University of Sheffield (GB)
Publication Details
- Journal
- Nature
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1038/s41586-025-08876-5
- Citations
- 21
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 29.15
Funders
- Biotechnology and Biological Sciences Research Council